Literature DB >> 2592557

The reactivity of desmosterol and other shellfish- and xanthomatosis-associated sterols in the macrophage sterol esterification reaction.

I Tabas1, S J Feinmark, N Beatini.   

Abstract

The acyl-CoA: cholesterol acyl transferase (ACAT) reaction in macrophages is a critical step in atherosclerotic foam cell formation, but little is known about the reaction's sterol substrate specificity. In this report we examine the macrophage ACAT reactivity of the shellfish sterol, desmosterol, and other sterols found in man because of shellfish ingestion or in association with the foam cell diseases sitosterolemia and cerebrotendinous xanthomatosis (CTX). We first show that the J774 macrophage, a foam cell model with a hyperactive ACAT pathway, synthesizes desmosterol instead of cholesterol and that both endogenous and exogenous desmosterol are substrates and stimulators of the ACAT reaction in these cells. When exogenous desmosterol was added to human monocyte-derived macrophages, ACAT was stimulated 29- and 4-fold compared with control and cholesterol-treated cells, respectively. Steryl ester mass accumulation in desmosterol-treated human macrophages was 10-fold greater than in control cells and 3-fold greater than in cholesterol-treated cells. Another shellfish sterol, 24-methylene cholesterol, also stimulated ACAT in human macrophages, but most of the xanthomatosis-related sterols did not stimulate ACAT. These data suggest that: (a) the shellfish sterols desmosterol and 24-methylene cholesterol may be atherogenic; and (b) the excessive foam cell formation seen in sitosterolemia and CTX cannot be explained by ACAT hyperreactivity of their associated sterols.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2592557      PMCID: PMC304047          DOI: 10.1172/JCI114354

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

Review 1.  Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism.

Authors:  K E Suckling; E F Stange
Journal:  J Lipid Res       Date:  1985-06       Impact factor: 5.922

2.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells.

Authors:  J L Goldstein; S K Basu; M S Brown
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  Selective inhibition of acyl coenzyme A:cholesterol acyltransferase by compound 58-035.

Authors:  A C Ross; K J Go; J G Heider; G H Rothblat
Journal:  J Biol Chem       Date:  1984-01-25       Impact factor: 5.157

4.  Inhibition of acyl coenzyme A:cholesterol acyl transferase in J774 macrophages enhances down-regulation of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl-coenzyme A reductase and prevents low density lipoprotein-induced cholesterol accumulation.

Authors:  I Tabas; D A Weiland; A R Tall
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

5.  Unmodified low density lipoprotein causes cholesteryl ester accumulation in J774 macrophages.

Authors:  I Tabas; D A Weiland; A R Tall
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  Foam cell-forming J774 macrophages have markedly elevated acyl coenzyme A:cholesterol acyl transferase activity compared with mouse peritoneal macrophages in the presence of low density lipoprotein (LDL) despite similar LDL receptor activity.

Authors:  I Tabas; G C Boykow; A R Tall
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  Acyl coenzyme A:cholesterol acyl transferase in macrophages utilizes a cellular pool of cholesterol oxidase-accessible cholesterol as substrate.

Authors:  I Tabas; W J Rosoff; G C Boykow
Journal:  J Biol Chem       Date:  1988-01-25       Impact factor: 5.157

8.  Increased plasma cholestanol and 5 alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis.

Authors:  G Salen; P O Kwiterovich; S Shefer; G S Tint; I Horak; V Shore; B Dayal; E Horak
Journal:  J Lipid Res       Date:  1985-02       Impact factor: 5.922

9.  Sterol substrate specificity of acyl coenzyme A:cholesterol acyltransferase from the corn earworm, Heliothis zea.

Authors:  S K Macauley; J T Billheimer; K S Ritter
Journal:  J Lipid Res       Date:  1986-01       Impact factor: 5.922

10.  Cytochrome P-450-dependent oxidation of lanosterol in cholesterol biosynthesis. Microsomal electron transport and C-32 demethylation.

Authors:  J M Trzaskos; W D Bowen; A Shafiee; R T Fischer; J L Gaylor
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

View more
  5 in total

1.  Desmosterol can replace cholesterol in sustaining cell proliferation and regulating the SREBP pathway in a sterol-Delta24-reductase-deficient cell line.

Authors:  Sara Rodríguez-Acebes; Paloma de la Cueva; Carlos Fernández-Hernando; Antonio J Ferruelo; Miguel A Lasunción; Robert B Rawson; Javier Martínez-Botas; Diego Gómez-Coronado
Journal:  Biochem J       Date:  2009-05-13       Impact factor: 3.857

2.  Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism.

Authors:  Sajesh Parathath; Stephanie L Mick; Jonathan E Feig; Victor Joaquin; Lisa Grauer; David M Habiel; Max Gassmann; Lawrence B Gardner; Edward A Fisher
Journal:  Circ Res       Date:  2011-09-15       Impact factor: 17.367

3.  The terminal enzymes of cholesterol synthesis, DHCR24 and DHCR7, interact physically and functionally.

Authors:  Winnie Luu; Gene Hart-Smith; Laura J Sharpe; Andrew J Brown
Journal:  J Lipid Res       Date:  2015-01-31       Impact factor: 5.922

4.  Inhibition of cholesterol biosynthesis by Delta22-unsaturated phytosterols via competitive inhibition of sterol Delta24-reductase in mammalian cells.

Authors:  Carlos Fernández; Yajaira Suárez; Antonio J Ferruelo; Diego Gómez-Coronado; Miguel A Lasunción
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

Review 5.  Autophagy in atherosclerosis.

Authors:  Wim Martinet; Guido R Y De Meyer
Journal:  Curr Atheroscler Rep       Date:  2008-06       Impact factor: 5.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.